EGIR

AcronymDefinition
EGIREuropean Group of Insulin Resistance
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Since dyslipidaemia was defined by either elevated TG or low HDL values or specific medication used for these conditions (similar to WHO and EGIR definition), it might have underestimated the real prevalence of MS, as cases with both lipid components were not recognized by this definition.
The criteria were then expanded to include the EGIR criteria in secondary analyses of a subsample of participants with data available on insulin resistance.
For example, the WHO and EGIR classifications require the measurement of insulin resistance (IR), which is determined by an oral glucose tolerance test and hyperinsulinemic--euglycemic clamp.
In the present work, we have estimated the prevalence of insulin resistance in obesity from the database of the European Group for the Study of Insulin Resistance (EGIR).
In response, the European Group for the study of Insulin Resistance (EGIR) countered with a modification of the WHO definition in 1999 [6].
Several definitions for metabolic syndrome in adult populations have been proposed by different organizations including the World Health Organization (WHO), the International Diabetes Federation (IDF), the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), the National Cholesterol Education Program Adult Treatment Panel III P(NCEP-ATP III), and the European Group for the Study of Insulin Resistance (EGIR) [15].
The criteria for MS were first described in 1998 by the World Health Organization (WHO) and subsequently described in 1999 by the European Group for the Study of Insulin Resistance (EGIR), in 2001 by the National Cholesterol Education Program Adult Treatment Panel (NCEP-ATP III), in 2003 by the American Association of Clinical Endocrinologists (AACE), in 2005 by the International Diabetes Federation (IDF) and again in 2005 by the American Heart Association and The National Heart, Lung, and Blood Institute (AHA/NHLBI), which described the revised NCEP-ATP III criteria.
(23.) Camastra S, Bonora E, Del Prato S, Rett K, Weck M, Ferrannini E; EGIR (European Group for the Study of Insulin Resistance).
In 1999, the European Group for the study of Insulin Resistance (EGIR) recommended more or less similar criteria with lower cut offs for hypertension.9
En la poblacion general la prevalencia del SM se estima por encima del 20% y en Espana oscila entre el 19,3% (criterios OMS) (10) y el 15,5% (criterios EGIR) (11).